text:
The concrete technology team works on final development and deployment of new equipment, materials, tools, and techniques.
A key element in our current program is the promotion of Advanced Structural Design and Rehabilitation Applications for Portland Cement Concrete. This initiative includes technology demonstrations as well as development and delivery of improved technical guidance and training programs. Examples of specific activities include:
View all Concrete Publications
The National Highway Institute website is a good source for all types of training courses offered by FHWA.
Suneel Vanikar Office of Asset Management, Pavement, and Construction 202-366-0120 E-mail Suneel
Jack Youtcheff Turner Fairbank (Materials and Construction) 202-493-3090 E-mail Jack
Tom Harman Resource Center (Baltimore) 410-962-0134 E-mail Tom
Katherine Petros Turner Fairbank (Modeling) 202-493-3154 E-mail Katherine


text:
Modern and Contemporary Art "Untitled" (Petit Palais) 1992 Felix Gonzalez-Torres, American (born Cuba), 1957 - 1996 Lightbulbs, porcelain light sockets, and extension cord Currently not on view 1992-99-1 Gift of the Peter Norton Family Foundation, 1992 |
LabelA simple string of light bulbs, Untitled (Petit Palais) rejects the monumental and heroic in favor of a quietly personal approach. The sculpture was inspired by lights Felix Gonzalez- Torres saw on Paris streets, and its title comes from the name of a Paris hotel. Made of everyday objects, it is designed to suggest a wide range of meanings, incorporating both the artist's and the viewer's responses and memories and reflecting upon the poignant tension between light's capacity for revelation and transcendence and its inevitable dimming over time. The modest and open-ended quality of the piece is reinforced by the fact that it has no fixed form of its own: the artist stipulated that whoever installed the work was to choose its configuration. |

subset: commoncrawl


text:
This ingenious lamp made from earthenware ceramic shows us that even amongst the hustle and bustle of everyday life, there is space for the pure and serene. The unusual and striking shape of this lamp, with its incandescent lighting, combines a blank palette with avant-garde design. Who said art is just for galleries?
EU standard plug. E14. Max. 40 W (not included). 2 meter cord length.


text:
Fun and strappy gladiator heels from the Funtasma collection. The Goddess-118 pairs well with a variety of costumes including a gladiator look. Faux leather Strappy look Lace-up design Metal eyelets Rear zipper Mini-platform Cord laces Lining: man-made Heel height: 4 ½ in. Platform height: ½ in.
Comments should be restricted to size, fit and other useful information for future customer purchases. Other comments can be expressed through testimonials and emails to our customer care. Comments may be edited if they contain vulgar language or are derogatory in nature.
Sorry, there is no information for this brand.
Men & Womens Shoes Size Conversion Chart
Kid's Shoes Conversion Chart
Men's to Women's Shoes Conversion Chart


text:
Pop Cult
Thoughts, ideas and videos from the world of movies, music, TV and everything else pop culture.
Rafer Guzman
Rafer Guzman is Newsday's film critic. He has also been Newsday's rock critic, a travel writer at The Wall Street Journal and music editor at the New Times Broward-Palm Beach.
He has a master's degree from Columbia University's School of Journalism and a B.A. in English from the University of California at Berkeley. His interests include
movies, music, writing about movies and music, and the search for some other kind of meaningful hobby.
Paramount announces $33 'Anchorman 2' SuperTicket
How do you feel about shelling out $33 to see "Anchorman 2"?
If that seems like kind of a big deal, consider what Paramount Pictures and AMC theaters are offering. First, you'll get to see the movie Dec. 16, two days ahead of its official theatrical debut. You'll also get a poster and a $5 voucher for the concession stand.
Most intriguing, the so-called SuperTicket comes with...
Read more »New 'Grace of Monaco' trailer offers first look at Nicole Kidman as the actress-princess
A trailer for "Grace of Monaco" is now on the Web, offering a first look at Nicole Kidman in the role of Grace Kelly, the Philadelphia-born beauty whose brief acting career (including Hitchcock's "Rear Window" and "To Catch a Thief") ended after she became Princess Grace of Monaco by marrying that principality's Prince Rainier III (played by Tim Roth).
Frank Langella, Derek Jacobi, Parker...
Read more »'RoboCop' trailer released
A trailer for the remake of the 1987 sci-fi classic "RoboCop" has hit the web, offering a look at Joel Kinnaman (AMC's "The Killing") replacing Peter Weller as Murphy, a badly injured cop who wakes up from surgery transformed into a peace-keeping cyborg.
You'll notice an eclectic cast of supporting actors, including Samuel L. Jackson, Gary Oldman and Michael Keaton, plus...
Read more »'Gravity' trailer released
"Gravity," the sci-fi thriller starring George Clooney and Sandra Bullock, has been under wraps for most of this year, but Warner Bros. has finally released a two-minute teaser trailer for the film.
It's an interesting project that appears to have essentially only two actors. Clooney plays a veteran astronaut assisting a scientist (Bullock) on her first space shuttle mission,...
Read more »Julianne Moore may join 'The Hunger Games,' reports say
The actress who recently played vice presidential candidate Sarah Palin in HBO's "Game Change" may play President Alma Coin in the final two "Hunger Games" films, according to reports.
Moore, 52, is said to be under consideration by the studio, Lionsgate, and director Francis Lawrence to play the role in the two-part adapation of Suzanne Collins' novel "The Hunger...
Read more »


text:
TheBull PREMIUM article search
Between now and 2050, the number of people aged 65 to 84 is expected to more than double, and those aged 85 or over will quadruple to 1.8 million.
Get GFT's guide and discover our top 10 tips about FX trading! Losses can exceed initial deposits
Find out more© Copyright The Compare Group Pty Ltd. All rights reserved.


text:
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Scleroderma Research Foundation
The Scleroderma Research Foundation with support from Gilead Sciences, MedImmune and Novartis brings the nation's top experts directly to the patients via a free webinar series
SAN FRANCISCO, Sept. 13, 2013 /PRNewswire-USNewswire/ -- Dr. Laura Hummers, Assistant Professor of Medicine and Co-Director of the Johns Hopkins Scleroderma Center, will host a patient-focused webinar on Tuesday, September 17, 2013 at 10 a.m. PDT. "What's New in the World of Scleroderma" will educate patients, family members and others about the latest treatment advances as well as current and future scleroderma research projects showing the most promise to improve patient quality of life.
An expert in her own right, Dr. Hummers has worked alongside the preeminent scleroderma physician Dr. Fredrick Wigley at the Hopkins center since 2003. She is a clinical research investigator and has concentrated her interest on scleroderma, where the focus of her research is the study of biomarkers to predict disease progression in scleroderma patients.
"Scleroderma is an often misdiagnosed and poorly understood disease by many patients and even frontline physicians," says Scleroderma Research Foundation Executive Director Amy Hewitt. "There is not enough information available to empower patients and, with our access to the leading experts in the field, we are trying to connect caregivers as well as patients to the information needed to better manage their disease and associated challenges."
Register online at https://cc.readytalk.com/r/f8p8a2mz0xqt&eom.
About Scleroderma
The word scleroderma means hard skin, but the disease is much more-often affecting the internal organs with life-threatening consequences. Scleroderma is considered a rare autoimmune disease and has one of the highest mortality rates of the rheumatic diseases. Women comprise 80% of the patient population with typical onset between the ages of 30 and 50. Scleroderma is characterized by widespread vascular abnormalities, immune dysregulation and fibrotic complications affecting multiple organs including the skin and lung. The disease is not contagious or directly hereditary and scientists are still searching for possible causes. There is no known cure and current therapies address various symptoms rather than truly arresting disease progression.
About Scleroderma Research Foundation:
The Scleroderma Research Foundation is America's leading nonprofit investor in scleroderma research. It was founded in San Francisco in 1987 by scleroderma patient Sharon Monsky who lost her battle to the disease in 2002. Monsky's legacy lives on through the organization, chaired by Luke Evnin, Ph.D., a scleroderma patient and managing partner of MPM Capital, one of the world's largest dedicated investors in life sciences.
The Foundation's collaborative approach is guided by a world-class Scientific Advisory Board and is empowering scientists from leading institutions to work together to develop an understanding of how scleroderma begins, how it progresses and what can be done to slow, halt or reverse the disease process.
About The Johns Hopkins Scleroderma Center
The Johns Hopkins Scleroderma Center specializes in the care of patients with scleroderma and related conditions such as Raynaud's phenomenon, localized scleroderma and pulmonary arterial hypertension. The Center's mission is to provide excellent clinical care while seeking to better understand the causes and best treatment approaches for scleroderma. All physicians at the Center are actively involved in clinical or translational research, looking for ways to expedite discoveries in the laboratory and apply them to new and better treatments for scleroderma patients.
For more information, call 1-800-441-CURE or visit www.sclerodermaRESEARCH.org. Follow the SRF on Facebook and Twitter.
©2012 PR Newswire. All Rights Reserved.
904 South Side Drive All content © Copyright 2000 - 2013, WorldNow and WAND. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms |